HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Zhang Selected Research

1 beta-D-ribofuranosylbenzimidazole cyclic 3',5'-phosphate (RBCP)

1/2019Fabrication of Red Blood Cell-Based Multimodal Theranostic Probes for Second Near-Infrared Window Fluorescence Imaging-Guided Tumor Surgery and Photodynamic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Zhang Research Topics

Disease

235Neoplasms (Cancer)
10/2022 - 07/2002
122Inflammation (Inflammations)
04/2022 - 01/2006
99Infections
06/2022 - 11/2004
89Atherosclerosis
03/2022 - 08/2004
76Fibrosis (Cirrhosis)
02/2022 - 11/2005
61Atherosclerotic Plaque (Atheroma)
03/2022 - 04/2007
39Neoplasm Metastasis (Metastasis)
01/2022 - 03/2009
35Breast Neoplasms (Breast Cancer)
06/2022 - 10/2002
31Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2008
30Hypertension (High Blood Pressure)
10/2021 - 10/2006
24Carcinogenesis
02/2022 - 12/2003
24Wounds and Injuries (Trauma)
01/2022 - 03/2002
23Insulin Resistance
01/2022 - 01/2006
22Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2022 - 02/2009
22Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2009
21Hypoxia (Hypoxemia)
01/2021 - 02/2006
20Ischemia
08/2021 - 01/2002
20Diabetic Cardiomyopathies
01/2021 - 01/2006
19Type 2 Diabetes Mellitus (MODY)
03/2022 - 01/2011
19Prostatic Neoplasms (Prostate Cancer)
08/2020 - 06/2004
19Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 07/2008
18Hypertrophy
01/2022 - 04/2005
18Rupture
01/2022 - 01/2004
18Myocardial Infarction
12/2020 - 12/2005
17Body Weight (Weight, Body)
01/2022 - 12/2005
17Diabetes Mellitus
01/2022 - 10/2006
17Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2008
17Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2006
16Hemorrhage
11/2022 - 03/2006
16Atrial Fibrillation
08/2022 - 01/2005
16Alzheimer Disease (Alzheimer's Disease)
01/2022 - 02/2002
16Lung Neoplasms (Lung Cancer)
11/2021 - 11/2008
16Stroke (Strokes)
04/2021 - 12/2002
15Ischemic Stroke
01/2022 - 10/2008
15Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2006
14Reperfusion Injury
02/2022 - 01/2002
14COVID-19
01/2022 - 05/2020
13Heart Failure
02/2022 - 05/2006
13Cognitive Dysfunction
01/2022 - 07/2013
13Pneumonia (Pneumonitis)
01/2022 - 01/2012
12Necrosis
11/2022 - 09/2008
12Parkinson Disease (Parkinson's Disease)
04/2022 - 01/2003
12Systemic Scleroderma (Systemic Sclerosis)
07/2021 - 06/2014
12Glioma (Gliomas)
07/2021 - 03/2002
12Hyperglycemia
01/2018 - 01/2006
11Virus Diseases (Viral Diseases)
06/2022 - 09/2004
11Abdominal Aortic Aneurysm
01/2022 - 06/2012
11Asthma (Bronchial Asthma)
01/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

154Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2002
68Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2007
63Pharmaceutical PreparationsIBA
06/2022 - 01/2002
51CytokinesIBA
01/2022 - 08/2007
46CollagenIBA
01/2022 - 10/2004
46Apolipoproteins E (ApoE)IBA
01/2022 - 05/2009
43LipidsIBA
01/2022 - 09/2005
42Messenger RNA (mRNA)IBA
04/2022 - 07/2002
35Glucose (Dextrose)FDA LinkGeneric
04/2022 - 03/2006
34MicroRNAs (MicroRNA)IBA
08/2021 - 01/2012
32ApolipoproteinsIBA
03/2022 - 03/2008
28EnzymesIBA
01/2022 - 01/2002
26Biological ProductsIBA
06/2022 - 07/2002
25Therapeutic UsesIBA
01/2022 - 09/2008
25VaccinesIBA
01/2022 - 09/2006
25Small Interfering RNA (siRNA)IBA
08/2021 - 12/2007
24Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 01/2011
24DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2002
20Peptides (Polypeptides)IBA
05/2022 - 02/2002
20CholesterolIBA
01/2022 - 01/2006
19Interleukin-6 (Interleukin 6)IBA
02/2022 - 05/2009
19Monoclonal AntibodiesIBA
12/2021 - 03/2002
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 08/2007
19C-Reactive ProteinIBA
01/2021 - 07/2004
19Angiotensin IIIBA
01/2020 - 07/2008
18Phosphotransferases (Kinase)IBA
04/2022 - 06/2002
17RNA (Ribonucleic Acid)IBA
01/2022 - 12/2005
16LipopolysaccharidesIBA
01/2022 - 05/2009
16Streptozocin (Streptozotocin)FDA Link
06/2020 - 01/2006
15LigandsIBA
11/2021 - 09/2011
15Estrogen ReceptorsIBA
01/2020 - 11/2002
14Insulin (Novolin)FDA Link
01/2022 - 01/2006
14oxidized low density lipoproteinIBA
01/2022 - 12/2006
14Matrix Metalloproteinases (MMPs)IBA
01/2022 - 02/2007
13AntioxidantsIBA
06/2022 - 03/2010
13Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 01/2011
13salicylhydroxamic acid (SHAM)IBA
01/2020 - 11/2004
12Transcription Factors (Transcription Factor)IBA
12/2022 - 10/2002
12Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 04/2009
12Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2006
11InflammasomesIBA
03/2022 - 01/2013
11angiotensin I (1-7)IBA
03/2022 - 07/2008
11AntibodiesIBA
10/2021 - 06/2006
11Long Noncoding RNAIBA
06/2021 - 01/2015

Therapy/Procedure

150Therapeutics
11/2022 - 12/2004
31Drug Therapy (Chemotherapy)
01/2022 - 08/2004
20Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2022 - 03/2007
19Radiotherapy
01/2022 - 05/2007
15Precision Medicine
11/2022 - 11/2015
12Aftercare (After-Treatment)
10/2021 - 09/2005
12Intravenous Administration
01/2016 - 03/2002
11Resuscitation
01/2022 - 11/2006